تقرير
أعرض في EDS

Early Achromobacter xylosoxidans Endocarditis After the Valvular Mitral Replacement Complicated by an Agranulocytosis on B-lactams: A Case Report.

التفاصيل البيبلوغرافية
العنوان: Early Achromobacter xylosoxidans Endocarditis After the Valvular Mitral Replacement Complicated by an Agranulocytosis on B-lactams: A Case Report.
المؤلفون: Channaoui A; Cardiac Surgery Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Dubus M; Cardiac Surgery Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Mathieu F; Cardiology Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Noirhomme S; Infectious Disease Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL., Fontaine R; Cardiac Surgery Department, Centre Hospitalier Régional Sambre et Meuse, Namur, BEL.
المصدر: Cureus [Cureus] 2023 Sep 27; Vol. 15 (9), pp. e46045. Date of Electronic Publication: 2023 Sep 27 (Print Publication: 2023).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: An immunocompetent 82-year-old woman developed endocarditis caused by an atypical organism called Achromobacter xylosoxidans, after a first valvular surgery. The intravenous antibiotic therapy with ceftazidime - 2 g every 8 hours during five weeks - a key part of the treatment, induced agranulocytosis as an adverse event. Cross-reactivity between antibiotics was suspected. Finally, the patient's cure was the result of a coordinated effort between medical and surgical professionals. Postoperative follow-up is six years.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Channaoui et al.)
References: Eur J Clin Microbiol Infect Dis. 2007 Jun;26(6):435-7. (PMID: 17516103)
Am J Case Rep. 2020 Jul 21;21:e923031. (PMID: 32747617)
G Ital Cardiol (Rome). 2016 Apr;17(4):277-319. (PMID: 27093212)
West J Med. 1982 Feb;136(2):153-7. (PMID: 7064475)
Clin Infect Dis. 2000 Apr;30(4):633-8. (PMID: 10770721)
J Med Microbiol. 2008 Apr;57(Pt 4):525-527. (PMID: 18349376)
J Thorac Cardiovasc Surg. 2019 Feb;157(2):555-566. (PMID: 30385026)
Can J Infect Dis Med Microbiol. 2011 Fall;22(3):e17-20. (PMID: 22942890)
Lancet. 2016 Feb 27;387(10021):882-93. (PMID: 26341945)
Autops Case Rep. 2017 Sep 30;7(3):50-55. (PMID: 29043211)
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):768-774. (PMID: 28575189)
Eur Heart J. 2023 Oct 14;44(39):3948-4042. (PMID: 37622656)
Intern Med. 2012;51(9):1133-8. (PMID: 22576403)
فهرسة مساهمة: Keywords: achromobacter xylosoxidans; adverse drug event; agranulocytosis; mitral endocarditis; mitral valve surgery
تواريخ الأحداث: Date Created: 20231030 Latest Revision: 20231031
رمز التحديث: 20231031
مُعرف محوري في PubMed: PMC10603368
DOI: 10.7759/cureus.46045
PMID: 37900458
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.46045